🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
BSX
NYSE
🇺🇸 US
Boston Scientific Corporation
Healthcare
54Score
DipBuster Score™
$45.29
+$0.34 (+0.76%)
Live price · Source: Yahoo
52-Week Position
$44.44
1% of range
$109.50
Beta
0.559
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.559
52W High$109.50
52W Low$44.44
🤖
Dip Signal — Score 54/100
Zone: Strong Buy
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position1% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.559
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Boston Scientific Corporation free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
39/25
Momentum & Volume
10/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟢
Dip Signal
DipBuster Score: 54/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interv…
Sector
Healthcare
Market
🇺🇸 US
CEO
Michael F. Mahoney
Staff
53,000 employees
Website